This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marques, M B Articles by Wessels, M R Search for Related Content PubMed PubMed Citation Articles by Marques, M B Articles by Wessels, M R

research-article

Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine.

Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts 02115.

ABSTRACT

Group B streptococci (GBS) are a major cause of sepsis and meningitis in infants. While antibodies directed to the type-specific GBS capsule have been shown to be protective, it is less clear whether antibodies to the group B polysaccharide, a noncapsular, cell wall-associated antigen, may play a role in immunity. To investigate the functional activity of group B polysaccharide-specific antibodies, we tested sera from rabbits vaccinated with group B polysaccharide coupled to tetanus toxoid (B-TT). Anti-B-TT was weakly opsonic in vitro for a highly encapsulated type III strain, while antiserum elicited by vaccination with type III capsular polysaccharide linked to tetanus toxoid (III-TT) was a very effective opsonin. In contrast to anti-III-TT, anti-B-TT given before or after bacterial challenge was only marginally effective in protecting newborn mice against lethal infection with type III GBS. The number of C3 molecules bound to type III GBS was augmented by anti-III-TT but not by high antibody concentrations of anti-B-TT. These results suggest that the difference in opsonic activity between anti-B-TT and anti-III-TT may be due to a difference in their ability to deposit C3. In addition, the maximum number of antibody molecules bound to the bacterial surface was greater for anti-III-TT than for anti-B-TT. That anti-B-TT binds to fewer sites than anti-III-TT may explain the differences in complement activation and in opsonic and protective efficacy of antibodies to group B polysaccharide compared with antibodies to the type-specific capsular polysaccharide.

This article has been cited by other articles:

• Sutcliffe, I. C., Black, G. W., Harrington, D. J. (2008). Bioinformatic insights into the biosynthesis of the Group B carbohydrate in Streptococcus agalactiae. Microbiology 154: 1354-1363 [Abstract] [Full Text]  
• Li, Y., Martinez, G., Gottschalk, M., Lacouture, S., Willson, P., Dubreuil, J. D., Jacques, M., Harel, J. (2006). Identification of a Surface Protein of Streptococcus suis and Evaluation of Its Immunogenic and Protective Capacity in Pigs. Infect. Immun. 74: 305-312 [Abstract] [Full Text]  
• Deng, L., Kasper, D. L., Krick, T. P., Wessels, M. R. (2000). Characterization of the Linkage between the Type III Capsular Polysaccharide and the Bacterial Cell Wall of Group B Streptococcus. J. Biol. Chem. 275: 7497-7504 [Abstract] [Full Text]  
• Ross, R. A., Madoff, L. C., Paoletti, L. C. (1999). Regulation of Cell Component Production by Growth Rate in the Group B Streptococcus. J. Bacteriol. 181: 5389-5394 [Abstract] [Full Text]  
• Bhushan, R., Anthony, B. F., Frasch, C. E. (1998). Estimation of Group B Streptococcus Type III Polysaccharide-Specific Antibody Concentrations in Human Sera Is Antigen Dependent. Infect. Immun. 66: 5848-5853 [Abstract] [Full Text]